Michael Powell, Director at Ocera Therapeutics, Inc. (OCRX), sold 706,508 shares at $2.29 ($15K) on 2016-09-12, disclosed to the SEC on 2016-12-30.
Open-market sale of $15k OCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.29 | 74 | $169 | 1.1% |
| 2 | $2.29 | 1,066 | $2K | 16.4% |
| 3 | $2.29 | 5,372 | $12K | 82.5% |
| 4 | $0.00 | 699,996 | $0 | 0.0% |
| Total | $0.02 avg | 706,508 | $15K | 100% |
| Filing → |
| MIRN | BUY | 2015-10-06 | $6.0M | — | Filing → |
| AERI | SELL | 2014-07-11 | $24.2M | — | Filing → |
| HPTX | SELL | 2014-03-05 | $709K | — | Filing → |